Advanced Fluid & Electrolyte Management

💧Body Fluid Compartments

Total Body Water ~60% of body weight (adult male)

Compartment	Fraction	~Volume (70kg)
Intracellular Fluid (ICF)	2/3 (≈67%)	28 L
Extracellular Fluid (ECF)	1/3 (≈33%)	14 L
↳ Intravascular (plasma)	ECF × 1/4	3.5 L
↳ Interstitial	ECF × 3/4	10.5 L

Key Nursing Point Women & obese patients have lower TBW (~50–55%). Elderly patients ↓TBW increases risk of rapid dehydration.

⚗️Osmolality vs Tonicity

Serum Osmolality = 2[Na] + [glucose]/18 + [BUN]/2.8
Normal: 275–295 mOsm/kg

Osmolality — all solutes (including urea which crosses membranes freely)
Tonicity (Effective Osmolality) — only solutes that do NOT cross cell membranes (Na, glucose) — drives water shifts
Isotonic 275–295 mOsm/kg — no net water movement
Hypertonic >295 — water moves out of cells → cell shrinkage
Hypotonic <275 — water moves into cells → cell swelling

Osmol Gap = Measured − Calculated Osm
Normal <10 mOsm/kg (↑ = ethanol/methanol/mannitol)

⚖️Starling Forces — Capillary Fluid Exchange

Forces FAVOURING Filtration (fluid OUT of capillary)

Capillary Hydrostatic Pressure (Pc) — blood pressure pushes fluid out (~32 mmHg arterial end, ~15 mmHg venous end)
Interstitial Oncotic Pressure (πi) — small proteins in interstitium pull fluid out (~3 mmHg)

Forces FAVOURING Reabsorption (fluid INTO capillary)

Plasma Oncotic Pressure (πc) — albumin pulls fluid in (~25–28 mmHg)
Interstitial Hydrostatic Pressure (Pi) — tissue pressure pushes fluid in (~3 mmHg)

Clinical Significance: Oedema Formation Low albumin (↓πc), ↑capillary pressure (heart failure), ↑capillary permeability (sepsis), or lymphatic obstruction all lead to oedema. Albumin <20 g/L = severe oedema risk.

📊Normal Daily Fluid Losses

Route	Volume/day	Notes
Urine	1,000–1,500 mL	Main regulated route
Insensible (skin+lungs)	~800 mL	↑ with fever (+150mL/°C)
Faeces	~200 mL	↑ massively with diarrhoea
Sweat (normal)	100–200 mL	↑↑ in GCC heat up to 2L/hr
Total Output	~2,000–2,500 mL	Must be replaced

Urine Output Target Minimum 0.5 mL/kg/hr — Below this consider oliguria → assess fluid status → consider fluid challenge or escalation.

📋Fluid Input/Output Charting

Fluid Balance = Total Inputs − Total Outputs

Document ALL inputs: IV fluids, oral fluids, NG feeds, medications in diluent, blood products
Document ALL outputs: urine (catheter or measured voids), NG aspirates, drains, stoma, wound, vomit, diarrhoea
Calculate hourly running balance in critically ill patients
Calculate 24-hour cumulative balance daily
Note: a positive balance of +3L over 24h in ICU is associated with worse outcomes
Insensible losses added as estimated 800–1000 mL/day
Document on EMR (EPIC/MEDITECH) using correct encounter flowsheet

🔍Clinical Assessment of Fluid Status

Hypovolaemia Signs

Skin turgor ↓ (tenting >2 sec)
Dry mucous membranes
Cap refill >2 seconds
↓ JVP (flat neck veins)
Tachycardia, hypotension
Oliguria (<0.5 mL/kg/hr)
Sunken eyes, concentrated urine
Postural hypotension (>20 mmHg drop)

Hypervolaemia Signs

Pitting oedema (sacral > pedal in bedbound)
Raised JVP (>4 cm above sternal angle)
Lung crackles (pulmonary oedema)
Third heart sound (S3)
Ascites, pleural effusion
Weight gain >1 kg/day
Frothy sputum (flash pulmonary oedema)

Assessment Tools

NICE fluid assessment: NEWS2, history, clinical exam, urinalysis
PCWP (invasive) — wedge pressure 6–12 mmHg normal
CVP — 0–8 cmH₂O normal (limited utility alone)
Fluid responsiveness: PLR test, stroke volume variation (SVV >13% = responsive)
Bedside ECHO — IVC collapsibility index
Urine osmolality >500 mOsm/kg = concentrated (dehydrated)

🔬Crystalloid vs Colloid Debate

Crystalloids

Small molecules freely cross capillary membrane
Only ~25% stays intravascular after 30 min
Safer, cheaper, widely available
Preferred for initial resuscitation (NICE, Surviving Sepsis)
Examples: 0.9% NaCl, Hartmann's, Plasmalyte, 5% glucose

Colloids

Large molecules remain intravascular longer
~70–80% stays intravascular
HES (hydroxyethyl starch) — AVOID in ICU (↑AKI & mortality — CHEST/6S trials)
Albumin 4–5%: considered in sepsis + hypoalbuminaemia (ALBIOS trial)
Gelatin (Gelofusine): used in GCC — coagulopathy risk

NICE IV Fluid Algorithm — 5 Rs Framework (CG174) Resuscitation → Routine maintenance → Replacement → Redistribution → Reassessment. Always reassess after each step.

🚨Fluid Resuscitation

Identify hypovolaemia: ↑HR, ↓BP, oliguria, delayed cap refill, mottling
Give 250–500 mL crystalloid bolus over 15–30 min (balanced solution preferred)
Reassess: HR, BP, cap refill, urine output, NEWS2
If improved → continue maintenance. If not → repeat bolus (max 2L crystalloid)
After 2L without improvement → senior review, consider vasopressors, ICU escalation
Document response to each bolus and time given

Sepsis 1-Hour Bundle Crystalloid 30 mL/kg within 1 hour for sepsis-induced hypoperfusion. Reassess for fluid overload if no improvement after initial boluses.

💊NICE IV Fluid Types — Adult Maintenance

Approximate daily needs:
Water: 25–30 mL/kg/day
Na⁺: 1 mmol/kg/day
K⁺: 1 mmol/kg/day

Paediatric — 4/2/1 Rule (Holliday-Segar)

Weight	mL/hr
First 10 kg	4 mL/kg/hr
Next 10 kg (11–20)	+ 2 mL/kg/hr
Each kg above 20 kg	+ 1 mL/kg/hr

🧪Common IV Fluid Comparison

Fluid	Na⁺ (mmol/L)	Cl⁻ (mmol/L)	K⁺	HCO₃/Lactate	Osmolality	Key Use / Caution
0.9% NaCl (Normal Saline)	154	154	0	None	308	Resuscitation; ⚠️ hyperchloraemic metabolic acidosis with large volumes (Cl⁻ 154 vs plasma 100)
Hartmann's (Ringer's Lactate)	131	111	5	Lactate 29	278	Preferred balanced crystalloid; avoid in severe liver failure (can't metabolise lactate)
Plasmalyte-148	140	98	5	Acetate/Gluconate	295	Most balanced — preferred in ICU; no lactate (safe in liver failure)
5% Glucose (Dextrose)	0	0	0	None	252	Free water — NOT for resuscitation; dilutes Na⁺; useful for hypernatraemia correction
Glucose 4% / NaCl 0.18%	31	31	0	None	284	Hypotonic maintenance — risk of hyponatraemia; avoid in neurosurgical patients
Human Albumin Solution 4–5%	~150	~120	Low	—	~310	Relative hypovolaemia + low albumin (<25 g/L); expensive; used in SBP prophylaxis, large-volume paracentesis
20% Mannitol	0	0	0	None	1100	Cerebral oedema — osmotic agent; monitor renal function & osmol gap

⚠️Hyperchloraemic Acidosis (0.9% NaCl Risk)

Cl⁻ 154 mmol/L in 0.9% NaCl vs plasma Cl⁻ ~100 mmol/L
Large volumes cause chloride load → hyperchloraemic non-anion gap metabolic acidosis
Mechanism: excess Cl⁻ → ↓ strong ion difference → ↓ HCO₃⁻
Associated with ↑AKI, ↑mortality in large cohort studies (SALT-ED, SMART trials)
Balanced crystalloids (Hartmann's/Plasmalyte) preferred — reduces AKI risk by ~15%
0.9% NaCl still appropriate for: hyponatraemia, hypochloraemic alkalosis, diluting blood products

🏥Colloid Choice in ICU

AVOID HES (Hydroxyethyl Starch) — ↑AKI, ↑RRT, ↑mortality (CHEST trial 2012, 6S trial 2012). Withdrawn in EU.
CAUTION Gelatins — coagulopathy risk, anaphylaxis. Widely used in GCC — monitor closely.
CONSIDER Albumin 20–25% — for resistant oedema with severe hypoalbuminaemia (<20 g/L)
EVIDENCE Albumin 4–5% — ALBIOS trial: safe in sepsis; reduces 28-day mortality when albumin <30 g/L (subgroup)
SAFE trial: albumin vs saline — no difference overall; saline worse in TBI (↑mortality)

📉Hyponatraemia — Na⁺ <135 mmol/L

Mild Na 130–134

Moderate Na 125–129

Severe Na <125

Critical Na <120

Clinical Features by Acuity

Severity / Speed	Features
Mild (acute)	Nausea, headache, malaise
Moderate	Confusion, disorientation, vomiting
Severe (acute <48h)	Seizures, respiratory arrest, cerebral herniation
Severe (chronic >48h)	Often minimal symptoms despite low Na — brain has adapted

🔍Hyponatraemia Causes by Volume Status

Type	Causes	Urine Na
Hypovolaemic (↓ECF, ↓Na)	Diuretics, vomiting, diarrhoea, Addison's, burns	Renal: >20 Extra-renal: <20
Euvolaemic (↔ECF, ↓Na)	SIADH, hypothyroidism, glucocorticoid deficiency, polydipsia	>40 mmol/L
Hypervolaemic (↑ECF, ↓Na)	Heart failure, cirrhosis, nephrotic syndrome, AKI/CKD	Renal: >20 Extrarenal: <20

📋SIADH Diagnostic Criteria (Schwartz-Bartter)

Serum osmolality <275 mOsm/kg
Urine osmolality >100 mOsm/kg (inappropriately concentrated)
Urine Na⁺ >40 mmol/L despite hyponatraemia
Clinical euvolaemia (no oedema, no dehydration)
Normal adrenal and thyroid function
No diuretic use

Common SIADH Causes in GCC

CNS: meningitis, stroke, SAH, TBI
Pulmonary: TB (common in GCC expat workers), pneumonia, COPD
Drugs: SSRIs, carbamazepine, cyclophosphamide, NSAIDs, PPIs
Malignancy: SCLC (ectopic ADH)
Postoperative (pain/nausea → ADH release)

⚠️Hyponatraemia Correction — Critical Safety Rules

Osmotic Demyelination Syndrome (ODS / Central Pontine Myelinolysis) Occurs when chronic hyponatraemia corrected TOO FAST. Brain adapted to low Na — rapid correction causes osmotic cell damage. Risk ↑ with: alcoholism, malnutrition, hypokalaemia, liver disease.

Correction Rate Limits

Chronic (>48h or unknown): MAX 8–10 mmol/L per 24 hours
High ODS risk: MAX 6–8 mmol/L per 24 hours
Acute (<48h, symptomatic): 1–2 mmol/L/hr for first 1–2 hours ONLY then revert to slow correction
If corrected too fast: consider D5W or desmopressin to re-lower Na (relowering is acceptable)

Treatment by Cause

Cause	Treatment
SIADH mild	Fluid restriction 500–1000 mL/day
SIADH refractory	Tolvaptan (V2 receptor antagonist) — monitoring in hospital; demeclocycline
Hypovolaemic	0.9% NaCl (cautiously)
Severe symptomatic any cause	3% NaCl (hypertonic saline) 100–150 mL IV over 20 min — ICU/HDU
Hypervolaemic	Treat underlying cause + fluid restriction

Monitoring Frequency Check Na⁺ 2-hourly initially when giving hypertonic saline. Once stable: 4–6 hourly. Stop/slow if correction exceeds 8 mmol/L in 24 hours. Document every Na⁺ result with time and rate of change.

📈Hypernatraemia — Na⁺ >145 mmol/L

Causes

Water loss in excess of Na: Diabetes insipidus (central/nephrogenic), osmotic diuresis (hyperglycaemia), profuse sweating, fever, tachypnoea
Inadequate water intake: Elderly/confused patients, intubated patients, nil-by-mouth without IV free water
Na gain: Hypertonic saline, sodium bicarbonate, hyperaldosteronism (rare)
GCC-specific: Outdoor workers, heat stroke victims, pilgrims (Hajj), prolonged Ramadan fasting without adequate hydration

Treatment

Correct underlying cause (DDAVP for central DI)
Replace free water deficit gradually
Prefer oral/NG free water if tolerated
IV: use 5% glucose or 0.45% NaCl
MAX correction: 10 mmol/L per 24 hours
Too rapid correction → cerebral oedema
Monitor Na⁺ 2–4 hourly during active correction

Free Water Deficit (L) =
0.6 × Weight(kg) × [(Na/140) − 1]

📉Hypokalaemia — K⁺ <3.5 mmol/L

Mild: 3.0–3.5 Moderate: 2.5–3.0 Severe: <2.5

Causes

Diuretics (most common — furosemide, thiazides)
Vomiting / nasogastric drainage (↓K⁺ + metabolic alkalosis → ↑renal K loss)
Diarrhoea / laxative abuse (direct GI loss)
Renal Tubular Acidosis (RTA type I & II)
Hypomagnesaemia (blocks tubular K reabsorption — must correct Mg first)
Insulin excess, β₂-agonists (shift K intracellularly)
Hyperaldosteronism (Conn's syndrome)
Inadequate dietary intake + anorexia

❤️Hypokalaemia — ECG Changes

ECG Progression with ↓K⁺

Flat / inverted T waves (early sign)
Prominent U waves (positive deflection after T wave — best seen in V2/V3)
T-U fusion, prolonged QT interval
ST depression
Ventricular ectopics, SVT
Ventricular tachycardia / Torsades de Pointes (K⁺ <2.5)
Ventricular fibrillation (K⁺ <2.0)

Digoxin toxicity markedly potentiated by hypokalaemia — check K⁺ before every digoxin dose

💊Hypokalaemia Replacement Protocol

Oral Replacement (preferred when >2.5 mmol/L, asymptomatic)

Mild: Sando-K® / Kay-Cee-L® — 40–80 mmol/day in divided doses
Dietary: bananas, oranges, potatoes, dried fruit
Recheck K⁺ in 24–48 hours

IV Replacement — Peripheral Line

MAX 10 mmol/hr via peripheral IV
Concentration MAX 40 mmol/L (more concentrated = phlebitis/burning)
MUST have cardiac monitoring if rate >10 mmol/hr

IV Replacement — Central Line

MAX 20 mmol/hr via central line
Concentration up to 40 mmol/50 mL (concentrated via syringe driver)
Continuous cardiac monitoring MANDATORY
Check K⁺ 1–2 hourly during rapid correction
Typical infusion: 40 mmol KCl in 100–250 mL NaCl 0.9% over 4 hours

NEVER give KCl IV bolus — causes immediate cardiac arrest. KCl ampoules should be stored separately from other medications (high-alert medication).

📈Hyperkalaemia — K⁺ >5.5 mmol/L

Mild: 5.5–6.0 Moderate: 6.0–6.5 Severe: >6.5 Critical: >7.0 or ECG changes

ECG Progression with ↑K⁺

Peaked (tall, narrow) T waves (K⁺ 5.5–6.5)
Prolonged PR interval, wide QRS
Flat/absent P waves (K⁺ ~7.0)
Sine wave pattern (QRS merges with T wave)
Ventricular fibrillation / Asystole

ECG changes = EMERGENCY regardless of K⁺ level. Act immediately.

Causes — "MACHINE"

Medications: ACEi, ARBs, spironolactone, NSAIDs, heparin, TMP-SMX
Acidosis (H⁺ shifts K⁺ out of cells)
Cellular destruction: rhabdomyolysis, tumour lysis, haemolysis, burns
Hypoaldosteronism / Addison's disease
Intake excess (rare with normal kidneys)
Nephropathy: AKI, CKD (most common in GCC)
Excretion failure: renal tubular acidosis type IV

🚨Hyperkalaemia Emergency Treatment — C-BIG-K-DROP

Step	Drug/Action	Dose/Detail	Mechanism	Onset
C	Calcium Gluconate 10%	10 mL IV over 5–10 min (repeat if ECG changes persist)	Membrane stabilisation — NOT lowering K⁺	1–3 min
B	Bicarbonate (8.4%)	50 mL IV (in severe acidosis)	Shifts K⁺ into cells (limited effect alone)	15–30 min
I	Insulin 10 units IV	+ Glucose 50mL of 50% dextrose	Stimulates Na/K ATPase → K⁺ intracellular shift	15–30 min
G	Glucose	Given with insulin to prevent hypoglycaemia	Monitor BGL 1-hourly × 6h post-insulin	—
K	Kayexalate / Resonium (calcium resonium)	15–30g orally or 30g enema	Ion exchange resin — removes K⁺ from gut	Hours
D	Dialysis	Emergency haemodialysis or CVVH	Removes K⁺ — definitive for refractory hyperkalaemia	Immediate
R	Resonium / Patiromer / ZS-9	Sodium zirconium cyclosilicate (Lokelma) 10g TDS × 2 days	Non-absorbed cation exchangers	1–6 hrs (ZS-9 faster)
O/P	Salbutamol nebuliser	10–20 mg nebulised	β₂ agonist → K⁺ intracellular shift (± IV)	15–30 min

Pseudo-hyperkalaemia Check for haemolysed sample (red discoloured serum), very high WBC/platelet count, tourniquet too tight. Always repeat if unexpected result with no clinical features.

🦴Hypocalcaemia — Corrected Ca²⁺ <2.2 mmol/L

Corrected Calcium Formula

Corrected Ca = Measured Ca + 0.02 × (40 − albumin g/L)

Clinical Features — Neuromuscular Excitability

Chvostek's Sign — tap facial nerve anterior to ear → ipsilateral facial twitch
Trousseau's Sign — inflate BP cuff above systolic for 3 min → carpal spasm (most specific)
Perioral numbness, tingling fingers/toes
Muscle cramps, tetany, laryngospasm (severe)
Seizures, prolonged QT → Torsades de Pointes
Psychiatric: anxiety, depression, confusion

Common Causes

Post-parathyroidectomy / thyroidectomy (hungry bone syndrome)
Hypomagnesaemia (blocks PTH secretion/action)
Hypoparathyroidism
Pancreatitis (calcium saponification)
Vitamin D deficiency (extremely common in GCC — despite sun exposure — due to clothing, indoor lifestyle)
Massive blood transfusion (citrate chelates Ca²⁺)
Sepsis / critical illness

💊Hypocalcaemia Treatment

Symptomatic / Severe Ca²⁺ <1.9 mmol/L IV Calcium Gluconate 10% — 10 mL (2.2 mmol Ca²⁺) IV over 10 minutes. Can repeat ×2. Then infusion: 40 mL 10% calcium gluconate in 500 mL 5% glucose over 6–12 hours. Monitor ECG during IV calcium.

Calcium Chloride 10% (10 mL = 6.8 mmol Ca²⁺) 3× more elemental Ca than gluconate — use in cardiac arrest, via central line only (causes tissue necrosis if extravasates).

Mild/Asymptomatic (Ca²⁺ 1.9–2.2)

Oral calcium carbonate 1–3g/day in divided doses
Vitamin D supplementation (cholecalciferol 800–2000 IU/day or alfacalcidol)
Correct hypomagnesaemia first — otherwise Ca replacement ineffective
Dietitian referral for dietary sources: dairy, fortified foods
Recheck Ca²⁺, Mg²⁺, PO₄, PTH, vitamin D levels

📈Hypercalcaemia — Corrected Ca²⁺ >2.7 mmol/L

Mnemonic: Stones, Bones, Groans, Psychic Moans (+ ↑BP) Renal stones, bone pain, abdominal pain/constipation/nausea, confusion/depression/fatigue. Symptoms usually with Ca²⁺ >3.0.

Causes — "CHIMPANZEES"

Calcium supplementation excess
Hyperparathyroidism (primary — most common outpatient)
Immobilisation (prolonged)
Malignancy (most common inpatient — PTHrP, osteolytic mets)
Paget's disease
Addison's disease
Zollinger-Ellison (MEN1)
Excessive Vitamin D
Excess milk alkali (rare)
Sarcoidosis / granulomatous disease

Treatment (by severity)

Severity	Treatment
Mild 2.7–3.0	Oral hydration, treat cause, avoid thiazides, low Ca diet
Moderate 3.0–3.5	IV 0.9% NaCl 200–300 mL/hr (rehydrate first — most important step), monitor fluid balance
Severe >3.5 or symptoms	Aggressive IV saline hydration, IV bisphosphonate (zoledronic acid 4mg or pamidronate 90mg), calcitonin for rapid reduction
Malignant hypercalcaemia	Denosumab 120mg SC (preferred in renal impairment), bisphosphonates, treat underlying cancer

🧲Hypomagnesaemia — Mg²⁺ <0.7 mmol/L

Causes

GI losses: diarrhoea, malabsorption, chronic alcohol use
Drugs: PPI (long-term), cisplatin, amphotericin B, diuretics
Diabetes mellitus (osmotic diuresis)
Renal wasting: Bartter's/Gitelman's syndrome, hypomagnesaemia-hypercalciuria

Clinical Features

Neuromuscular: tremor, tetany, weakness, Chvostek's, Trousseau's
Cardiac: prolonged QT, Torsades de Pointes, AF/VT
Refractory hypokalaemia and hypocalcaemia (due to Mg²⁺ deficiency)
Confusion, personality change

IV Magnesium Sulphate Protocol

Symptomatic / severe (<0.4 mmol/L): Mg sulphate 20% 10 mL (2g, 8 mmol) IV over 20–30 min
Maintenance infusion: 2–5g MgSO₄ in 250 mL NaCl over 4–12 hours
Oral mild: Magnesium glycerophosphate 4–24 mmol/day
Monitor: respiratory rate (<12/min → hold), knee reflexes (loss = toxicity), urine output
Antidote for Mg toxicity: Calcium gluconate 10% 10 mL IV
Eclampsia protocol: 4g loading dose + 1–2g/hr infusion (UK Eclampsia Trial)

🔋Hypophosphataemia — PO₄ <0.8 mmol/L

Key Context: Refeeding Syndrome

Refeeding Syndrome Risk Occurs when refeeding malnourished patients (BMI <16, minimal intake >5 days, massive weight loss, prolonged fasting, alcohol abuse, cancer). Insulin surge drives PO₄, K⁺, Mg²⁺ into cells → severe hypophosphataemia.

Clinical Features of Hypophosphataemia

Muscle weakness → respiratory failure (diaphragm weakness → ventilator dependence)
Haemolytic anaemia, platelet dysfunction
Confusion, seizures, coma
Cardiac failure (<0.3 mmol/L)
Inability to wean from ventilator in ICU — common clinical scenario

Treatment

Mild 0.6–0.8: Oral phosphate effervescent tablets (Phosphate-Sandoz)
Moderate 0.3–0.6: IV phosphate 0.2–0.4 mmol/kg over 4–6 hours
Severe <0.3: IV phosphate 0.4–0.5 mmol/kg over 6 hours; recheck 4-hourly
Refeeding syndrome prevention: start feeds at 50% target rate, replace electrolytes before starting feeds (NICE CG32)
Thiamine 200–300 mg IV before any glucose in high-risk patients

GCC-Specific Clinical Context The Gulf region presents unique electrolyte challenges: extreme heat (45–50°C summers), high CKD burden from diabetes and hypertension, large expatriate worker populations, religious fasting, and multi-ethnic patient populations.

🌡️Dehydration from Gulf Heat

Ambient summer temperatures: 45–50°C (feels up to 55–60°C with humidity)
Sweat rates during outdoor labour: 1–2 litres/hour
Construction workers: 12-hour shifts in direct sun — cumulative fluid deficit 5–10L common
Sweat electrolyte content: Na 20–80 mmol/L, K 4–8 mmol/L, Cl 20–60 mmol/L
Risk groups: construction workers, domestic workers, farmers, pilgrims on Hajj/Umra
Hyponatraemic dehydration: occurs when water replaced without salt (excessive plain water intake)
Assessment: urine SG >1.025, urine colour dark yellow, serum osmolality >295, Hct elevated

Heat Stroke Electrolyte Chaos Core temp >40°C + CNS dysfunction. Causes: rhabdomyolysis → ↑K⁺ + myoglobinuria → AKI → hyperkalaemia cascade. Also: ↓Na (sweat losses), ↓Ca (hypoalbuminaemia), ↓Mg, ↑PO₄ (rhabdomyolysis). ICU admission mandatory. Aggressive cooling + electrolyte correction + IV fluid (Hartmann's preferred).

🌙Ramadan Fasting — Electrolyte Changes

Fasting period: dawn to sunset (~12–18 hours depending on season)
No fluid intake during fasting hours — leads to mild-moderate hypovolaemia by evening
Serum sodium: may ↑ slightly during fast (dehydration effect), normalises after iftar
Serum potassium: variable — depends on diet quality at suhoor/iftar
Glucose and lipids: significant fluctuation — affects insulin requirements in diabetic patients
Risk of acute kidney injury: pre-existing CKD patients (advise medical exemption if GFR <30)
Medication timing: many oral electrolyte supplements, diuretics need timing adjustment
Nursing role: educate on signs of dehydration, when to break fast (medical emergency), adequate suhoor fluid intake

Patient Education Points (Arabic/Urdu/Hindi literacy) Use visual tools for fluid balance education. Many GCC hospitals maintain multilingual patient education materials (Arabic, English, Urdu, Hindi, Tagalog, Malayalam). Ensure discharge instructions on fluid intake are available in patient's language.

💧Oral Rehydration Solutions (ORS)

WHO ORS Formula (2002 Reduced Osmolarity)

Component	Amount/L
Sodium Chloride	2.6 g/L
Trisodium citrate	2.9 g/L
Potassium Chloride	1.5 g/L
Glucose (anhydrous)	13.5 g/L
Osmolarity	245 mOsm/L
Na⁺	75 mmol/L
K⁺	20 mmol/L

Common GCC ORS Brands

Brand	Available in	Notes
Dextrolyte	UAE, KSA, Kuwait, Bahrain	Widely available in pharmacies, sachets
Pedialyte	All GCC countries	Paediatric standard, also used in adults
ORS Sachets (WHO)	MOH/hospital pharmacy	Generic, low cost
Gastrolyte	KSA, UAE	Contains citrate, orange flavour available

Sports drinks (Gatorade, Pocari Sweat) NOT equivalent to ORS — insufficient sodium for dehydration treatment, but acceptable for mild heat-related hydration maintenance.

🏥Dialysis Electrolyte Management (High GCC CKD Burden)

GCC has among highest rates of T2DM and HTN globally → leading causes of CKD and ESRD
Saudi Arabia: ESRD prevalence ~490/million; UAE ~380/million
Standard haemodialysis bath: Na 138, K 2.0, Ca 1.25, HCO₃ 35–38 mmol/L
Pre-dialysis hyperkalaemia: most common electrolyte emergency in dialysis units
Dietary K restriction: <2,000 mg/day for HD patients (limit dates, dried fruits — very culturally important in GCC — counsel sensitively)
Phosphate management: calcium-based binders (CaCO₃) or sevelamer, taken WITH meals
Dialysis disequilibrium: avoid rapid urea/Na correction in first dialysis session (cerebral oedema risk)
CRRT (continuous renal replacement therapy): citrate anticoagulation → monitor ionised Ca²⁺ closely (citrate chelates Ca)

💻IV Fluid Charting in GCC EMR Systems

EPIC (widely used: Cleveland Clinic Abu Dhabi, Hamad Medical Qatar, King's College Hospital Dubai)

Document IV fluids under "Medication Administration" flowsheet
Fluid balance tracked automatically from MAR entries vs urimeter readings
iView: fluid input/output module — enter every void, drain, and NG output manually
Smart Pump (Alaris/BD) integration — IV rates feed directly into EPIC fluid balance in some centres

MEDITECH (used in some MOH hospitals: KSA, Oman)

Nursing flowsheet: "Intake and Output" module
Manual entry for all fluid items — double-check entries for accuracy
Alert: MEDITECH does not auto-calculate balance — nurse must sum manually or run I&O report

Documentation Standard Document frequency, volume, route, site, and patient response for every IV fluid prescription. Flag discrepancies immediately. Positive cumulative balance >3L → notify medical team.